Baxter International Inc. BAX NYSE

NYSE • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score

43/100

2/7 Pass

SharesGrow Intrinsic Value

Il y a eu 50 transactions d'initiés récentes enregistrées pour Baxter International Inc. (BAX), dont 25 achats et 21 ventes. Le total des achats d'initiés s'élève à $30.52M et le total des ventes d'initiés à $2.92M.

Les initiés notables ayant une activité récente comprennent Grade Joel T., Zielinski Anita A, Rosenbloom David S.. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — BAX

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2026-03-06	Grade Joel T.	EVP and CFO	Retenue Fiscale RSU	8,153	$17.69	$144.23K	271,674
2026-03-06	Zielinski Anita A	SVP, CAO and Controller	Retenue Fiscale RSU	1,932	$17.69	$34.18K	46,281
2026-03-06	Rosenbloom David S.	EVP and General Counsel	Retenue Fiscale RSU	6,620	$17.69	$117.11K	138,216
2026-03-06	Rasul Reazur	EVP,group Pres,healthcare	Retenue Fiscale RSU	12,674	$17.69	$224.2K	125,557
2026-03-06	Soriano Maria Cecilia	Group Pres., Itt & Pharma.	Retenue Fiscale RSU	2,848	$17.69	$50.38K	75,045
2026-03-02	Rosenbloom David S.	EVP and General Counsel	Retenue Fiscale RSU	1,336	$19.69	$26.31K	144,837
2026-03-02	Rasul Reazur	EVP,group Pres,healthcare	Retenue Fiscale RSU	1,614	$19.69	$31.78K	138,231
2026-03-02	Soriano Maria Cecilia	Group Pres., Itt & Pharma.	Retenue Fiscale RSU	1,852	$19.69	$36.47K	77,894
2026-02-27	Grade Joel T.	EVP and CFO	Attribution de RSU	103,448	$20.37	$2.11M	103,448
2026-02-27	Zielinski Anita A	SVP, CAO and Controller	Attribution de RSU	30,864	-	-	48,214
2026-02-27	Rosenbloom David S.	EVP and General Counsel	Attribution de RSU	64,655	$20.37	$1.32M	64,655
2026-02-27	Hider Andrew P.	President and CEO	Attribution de RSU	488,506	$20.37	$9.95M	488,506
2026-02-27	Carlisle Cynthia	Executive Vice President, Chro	Attribution de RSU	17,806	-	-	17,806
2026-02-27	Soriano Maria Cecilia	Group Pres., Itt & Pharma.	Attribution de RSU	57,471	$20.37	$1.17M	57,471
2026-02-23	Carlisle Cynthia	Executive Vice President, Chro	Inconnu	-	-	-	-
2026-02-13	Mcdonnell Michael R.	Director	Inconnu	-	-	-	-
2026-02-13	Mcdonnell Michael R.	Director	Attribution de RSU	1,811	-	-	1,811
2026-02-09	Grade Joel T.	EVP and CFO	Retenue Fiscale RSU	9,144	$21.73	$198.7K	236,904
2026-02-09	Rosenbloom David S.	EVP and General Counsel	Retenue Fiscale RSU	5,225	$21.73	$113.54K	119,464
2026-02-09	Rasul Reazur	EVP,group Pres,healthcare	Retenue Fiscale RSU	5,770	$21.73	$125.38K	139,846
2026-02-09	Soriano Maria Cecilia	Group Pres., Itt & Pharma.	Retenue Fiscale RSU	918	$21.73	$19.95K	56,006
2025-12-12	Mason Jeanne K	EVP, Chief HR Officer	Retenue Fiscale RSU	650	$19.15	$12.45K	199,853
2025-12-01	Grade Joel T.	EVP and CFO	Retenue Fiscale RSU	8,288	$19.08	$158.14K	215,151
2025-12-01	Soriano Maria Cecilia	Group Pres., Itt & Pharma.	Inconnu	23,787	$35.44	$843.01K	-
2025-09-02	Borzi James W	EVP,chief Supply Chain Officer	Retenue Fiscale RSU	1,848	$24.17	$44.67K	71,948
2025-09-02	Grade Joel T.	EVP and CFO	Attribution de RSU	102,712	-	-	222,560
2025-09-02	Hider Andrew P.	President and CEO	Attribution de RSU	236,237	-	-	236,237
2025-09-02	Sonig Alok	EVP,group President,pharma	Retenue Fiscale RSU	3,191	$24.17	$77.13K	128,219
2025-08-19	Shafer David Brent	Other: Chair of the Board	Retenue Fiscale RSU	31,337	$24.33	$762.43K	59,446
2025-08-19	Hider Andrew P.	President and CEO	Inconnu	-	-	-	-
2025-06-02	Rosenbloom David S.	EVP and General Counsel	Retenue Fiscale RSU	16,548	$29.55	$488.99K	106,327
2025-05-06	Rusckowski Stephen H	Director	Attribution de RSU	7,183	-	-	16,499
2025-05-06	Oesterle Stephen N.	Director	Attribution de RSU	7,183	-	-	35,847
2025-05-06	Morrison Patricia	Director	Attribution de RSU	7,183	-	-	29,137
2025-05-06	Smith Cathy R	Director	Attribution de RSU	7,183	-	-	30,345
2025-05-06	Craig Jeffrey A	Director	Attribution de RSU	7,183	-	-	10,672
2025-05-06	Schlichting Nancy M	Director	Attribution de RSU	7,183	-	-	21,850
2025-05-06	Wendell Amy Mcbride	Director	Attribution de RSU	7,183	-	-	31,222
2025-05-06	Wilkes David S.	Director	Attribution de RSU	7,183	-	-	23,906
2025-05-06	Ampofo William A. Ii	Director	Attribution de RSU	7,183	-	-	17,299
2025-03-06	Mason Jeanne K	EVP, Chief HR Officer	Attribution de RSU	52,331	$35.44	$1.85M	52,331
2025-03-06	Borzi James W	EVP,chief Supply Chain Officer	Attribution de RSU	33,302	$35.44	$1.18M	33,302
2025-03-06	Grade Joel T.	EVP and CFO	Retenue Fiscale RSU	4,306	$35.44	$152.6K	88,896
2025-03-06	Zielinski Anita A	SVP, CAO and Controller	Attribution de RSU	17,123	-	-	17,123
2025-03-06	Rosenbloom David S.	EVP and General Counsel	Attribution de RSU	58,873	$35.44	$2.09M	58,873
2025-03-06	Sonig Alok	EVP,group President,pharma	Attribution de RSU	99,905	$35.44	$3.54M	99,905
2025-03-06	Rasul Reazur	EVP,group Pres,healthcare	Attribution de RSU	87,417	$35.44	$3.1M	87,417
2025-03-06	Knight Heather	EVP, Chief Operating Officer	Attribution de RSU	118,934	$35.44	$4.22M	118,934
2025-03-03	Mason Jeanne K	EVP, Chief HR Officer	Retenue Fiscale RSU	1,479	$34.86	$51.56K	188,339
2025-03-03	Borzi James W	EVP,chief Suppy Chain Officer	Retenue Fiscale RSU	1,339	$34.86	$46.68K	66,407

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration